Smarter” Breast Cancer Screening Measures Risk Down to Your DNA

The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.

Genetic Testing - SimonMed Website

Cancer type classification using plasma cell-free RNAs derived from human and microbes

Germline variants in cancer genes in high-risk non-BRCA patients

12 Gene Breast Cancer Panel

Beyond BRCA and breast cancer risk

IJERPH, Free Full-Text

FDA Authorizes First Genetic Test to Assess Risk of Multiple

AI as a new paradigm for risk-based screening for breast cancer

Frontiers Cell-Free DNA: Hope and Potential Application in Cancer

Laura Esserman on LinkedIn: “Smarter” Breast Cancer Screening Measures Risk Down to Your DNA

Prostate cancer genetic testing: familial mutation, panels, exome

Screening for Breast Cancer - Asian Fund for Cancer Research

Frontiers Peripheral Blood-Based Biopsy for Breast Cancer Risk Prediction and Early Detection

In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target - ScienceDirect

service - St. Mary Medical Centre